A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints
Open Access
- 7 March 2023
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (5) , e30270
Abstract
Background: Radiation therapy normal tissue dose constraints are critical when treating pediatric patients. However, there is limited evidence supporting proposed constraints, which has led to variations in constraints over the years. In this study, we identify these variations in dose constraints within pediatric trials both in the United States and in Europe used in the past 30 years.Procedure: All pediatric trials from the Children's Oncology Group website were queried from inception until January 2022 and a sampling of European studies was included. Dose constraints were identified and built into an organ‐based interactive web application with filters to display data by organs at risk (OAR), protocol, start date, dose, volume, and fractionation scheme. Dose constraints were evaluated for consistency over time and compared between pediatric US and European trialsResults: One hundred five closed trials were included—93 US trials and 12 European trials. Thirty‐eight separate OAR were found with high‐dose constraint variability. Across all trials, nine organs had greater than 10 different constraints (median 16, range 11–26), including serial organs. When comparing US versus European dose tolerances, the United States constraints were higher for seven OAR, lower for one, and identical for five. No OAR had constraints change systematically over the last 30 years.Conclusion: Review of pediatric dose‐volume constraints in clinical trials showed substantial variability for all OAR. Continued efforts focused on standardization of OAR dose constraints and risk profiles are essential to increase consistency of protocol outcomes and ultimately to reduce radiation toxicities in the pediatric population.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Normal Tissue Development, Homeostasis, Senescence, and the Sensitivity to Radiation Injury Across the Age SpectrumSeminars in Radiation Oncology, 2010
- Radiation-Related Treatment Effects Across the Age Spectrum: Differences and Similarities or What the Old and Young Can Learn from Each OtherSeminars in Radiation Oncology, 2010
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Chronic Health Conditions in Adult Survivors of Childhood CancerOncology Times, 2007
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Predicting age of ovarian failure after radiation to a field that includes the ovariesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Genetic effects of radiotherapy for childhood cancer: Gonadal dose reconstructionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004